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Translational inhibitionLuteinizing hormone receptor (LHR) mRNA is post-transcriptionally regulated during ligand-induced
downregulation. This process involves interaction of LHR mRNA with a speciﬁc mRNA-binding protein
(LRBP), identiﬁed as mevalonate kinase (MVK), resulting in inhibition of translation followed by targeting
the ribonucleoprotein complex to accelerated degradation. The present study investigated the endogenous
association of LRBP with the translational machinery and its interaction with LHR mRNA during LH/hCG-
induced downregulation. Ovaries were collected from rats that were injected with the ligand, hCG, to induce
downregulation of LHR mRNA expression. Western blot analysis showed signiﬁcantly higher levels of LRBP in
polysomes from downregulated ovaries compared to controls. Western blot analysis of ribosome-rich
fractions from FPLC-assisted gel ﬁltration of post-mitochondrial supernatants conﬁrmed the presence of
LRBP in translating ribosomes isolated from the downregulated state but not from controls. The association
of LRBP with LHR mRNA in the downregulated polysomes was demonstrated by immunoprecipitation with
LRBP antibody followed by qPCR analysis of the associated RNA. Increased association of LHR mRNA with
LRBP during downregulation was also demonstrated by subjecting the polysome-associated RNAs to oligo
(dT) cellulose chromatography followed by immunoprecipitation and qPCR analysis. Additionally, analysis of
in vitro translation of LHR mRNA showed increased inhibition of translation by polysomes from
downregulated ovaries compared to control. This study provides strong in vivo and in vitro evidence to
show that during ligand-induced downregulation, LRBP translocates to ribosomes and associates with LHR
mRNA to form an untranslatable ribonucleoprotein complex and inhibits LHR mRNA translation, paving the
way to its degradation.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Luteinizing hormone (LH) receptor, a member of the rhodopsin-
like family of G protein-coupled receptors, is post-transcriptionally
regulated by an RNA-binding protein during downregulation [1,2].
The RNA-binding protein in rat ovary as well as in human granulosa
cells binds to a cytidine-rich region of the LH receptor mRNA [1–4].
RNA gel electrophoretic mobility shift assay (REMSA) and hydroxyl-
radical RNA footprinting of the partially puriﬁed LH receptor mRNA-
binding protein (LRBP) showed that the LRBP binding site is located in
the LH receptor open reading frame and binds to a polypyrimidine
sequence within nucleotides 203 and 220 of the LH receptor mRNA
with a high degree of speciﬁcity [2]. The identity of this LH receptor
mRNA-binding protein was then established as mevalonate kinase
(MVK) [5]. LRBP, puriﬁed to homogeneity, was able to bind LHRmRNA
directly. Furthermore, puriﬁed LRBP was recognized by rat mevalo-
nate kinase antibody in Western blots performed with one- and two-+1 734 936 8617.
n).
ll rights reserved.dimensional SDS–polyacrylamide gels [5]. Recombinant mevalonate
kinase produced in human embryonic kidney cells (293 cells) showed
all of the characteristics of LRBP with respect to speciﬁcity of LH
receptor mRNA-binding sequence [5]. The functional role of LRBP in
LH receptor mRNA downregulation has been established in our
laboratory [6] and, independently, by Ikeda et al. [7]. Furthermore, the
binding of the protein to LH receptor mRNA was shown to be
enhanced during ligand-induced downregulation [8]. We have also
demonstrated that in a cell-free translation system, partially puriﬁed
LRBP prevents the translation of LH receptor mRNA and that the intact
catalytically important residues of MVK are necessary for translational
suppression [9,10]. The ability of LRBP to block translation of LH
receptor mRNA was speciﬁc since translation of non-relevant mRNA
such as human β-actin was not affected [10]. While these studies
established a role of LRBP in suppressing LH receptor mRNA
translation, the association of LRBP with ribosomes has not been
demonstrated during ligand-induced downregulation.
In the present study, we hypothesize that LRBP, a cytosolic protein,
translocates to the ribosomes during downregulation and interacts
with LH receptormRNA to cause translational suppression. Our results
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LRBP with the translating LH receptor mRNA to form an untranslat-
able mRNP complex, thus inhibiting translation and leading to its
degradation.
2. Materials and methods
2.1. Materials
Pregnant mare serum gonadotrophin (PMSG) was purchased from
Calbiochem (San Diego, CA). Highly puriﬁed human chorionic
gonadotrophin (hCG; CR 127) was purchased from Dr. A.F. Parlow
(National Hormone and Peptide Program, Torrance, CA). Enlightening
reagent, [α-32P]UTP, and Redivue L-[35S]methionine were obtained
from Perkin Elmer Life Sciences (Waltham, MA). mMessage mMa-
chine T7 ultra and Maxiscript T7 were products of Ambion (Austin,
TX). EDTA-free protease inhibitor mixture tablets and Quickspin (G-
50 Sephadex) columns for radiolabeled RNA puriﬁcation were
purchased from Roche Applied Science (Indianapolis, IN) and Anti-
FLAG M2–agarose afﬁnity gel was purchased from Sigma (St. Louis,
MO). RNase inhibitor (rRNasin) and Flexi Rabbit Reticulocyte Lysate
System were from Promega (Madison, WI). Primers speciﬁc for LH
receptor, β-actin, GAPDH, and RPS6 mRNA and 18S rRNA (TaqMan
Assay-on-Demand Gene Expression Product) and Multiscribe reverse
transcriptase were from Applied Biosystems (Foster City, CA). Since
LRBP was identiﬁed as MVK, anti-N-terminal mevalonate kinase IgG
was raised against the ﬁrst 15 N-terminal amino acids of MVK
(MLSEVLLVSAPGKVI) and this antibody is referred to as the LRBP
antibody in the text. Puriﬁed antibodies against ribosomal protein S6
(RPS6; Cell Signaling, Beverly, MA) and heat shock protein 90β
(HSP90β; Assay Designs, Ann Arbor, MI) were commercial products.
The Super Signal West Femto chemiluminescence kit and anti-rabbit/
anti-mouse IgG conjugated to horseradish peroxidase were obtained
from Pierce (Rockford, IL). BCA reagent and oligo(dT) cellulose were
products of GE Healthcare Life Sciences (Piscataway, NJ).
2.2. Animals and tissues
Pseudopregnancy was induced in 23-day-old Sprague-Dawley rats
by subcutaneous injection of 50 IU of PMSG followed by 25 IU of hCG
56 h later. The day of hCG injection was taken as 0. LH receptor
downregulation was induced by the injection of 50 IU of hCG on the
5th day of pseudopregnancy. Ovaries were collected at 0, 2, 4, 6, and
12 h after hCG injection and were frozen in liquid nitrogen until
further use.
2.3. Preparation of tissue extracts, polysomes, and ribosomal salt wash
Ovaries from control and hCG-injected rats were homogenized in
solution A (1 mM potassium acetate, 2 mM Mg(Ac)2, 2 mM
dithiothreitol, and 10 mM Tris acetate, pH 7.6) at 4 °C. After
centrifugation at 10,000×g for 10 min, the supernatants were layered
over a cushion of solution B (solution A containing 30% sucrose) and
centrifuged at 130,000×g for 2.5 h. The polyribosome pellets were
resuspended in solution A and stored at 80 °C. Quantitation of
polysomeswas performed bymeasuring the absorbance at 260 nm. To
obtain ribosomal salt wash (RSW), equal amounts of polysomes from
control and downregulated conditions were resuspended in solution
A and were supplemented with 4 M KCl to a ﬁnal concentration of 0.5
M and incubated at 4 °C for 15 min. The high salt-treated ribosomes
were layered on top of solution B and centrifuged at 130,000×g for 2.5
h at 4 °C to separate ribosomes and ribosome associated proteins. The
proteins were removed from the interface between the two layers,
buffer exchanged, and concentrated. Total protein content of the RSW
was measured using BCA assay.2.4. Western blot analysis
Polysomes and other protein samples were incubated with SDS
sample loading buffer and subjected to 10% SDS–PAGE under reducing
conditions followed by Western blot analysis as previously described
[6]. The presence of immune complexes was detected by
chemiluminescence.
2.5. Fast protein liquid chromatography (FPLC)-assisted gel ﬁltration
Post-mitochondrial supernatants (S10) were prepared by homog-
enizing the rat ovaries in 0.4 ml of lysis buffer containing 20 mM Tris
(pH 7.5), 100mMKCl, 5 mMMgCl2, 0.5% NP-40, and 100 U/ml RNasin
followed by centrifugation of the lysate at 10,000×g for 10min at 4 °C.
S10 was then applied to a Superose 6 HR 10/30 column (GE
Healthcare Life Sciences) equilibrated in lysis buffer without NP-40.
Gel ﬁltration was run on BioLogic DuoFlow FPLC device (Bio-Rad)
with a ﬂow rate of 0.5 ml/min and 24 fractions of 1 ml were collected.
Total RNA was extracted from 0.5 ml of each fraction with phenol/
chloroform according to standard procedure, precipitated with
ethanol, and dissolved in 1× TBE. Samples were resolved on a 1.2%
agarose gel and visualized by ethidium bromide. The remaining 0.5 ml
of each fraction was concentrated and used for Western blot analysis.
2.6. Immunoprecipitation of the RNP complex from ribosomes
Polysomes were homogenized in NET-2 buffer (50 mM Tris-HCl,
pH 7.4, 150 mM NaCl, and 0.05% NP-40) containing RNasin (100
units/0.5 ml of buffer) and protease inhibitors. The homogenates
were centrifuged at 10,000×g for 10 min at 4 °C. The supernatants
were collected and 1–1.5 mg of protein/ml of the extracts were used
for immunoprecipitation of RNP complex as described before [10]
using the procedure developed by Lerner and Steitz [11].
2.7. Real-time PCR (qPCR) analysis
Total RNAs were reverse transcribed and subjected to real-time
PCR quantitation as described before [6]. The fold change in gene
expression was calculated using the ΔΔCT method [12] with 18S rRNA
as the internal control.
2.8. Oligo(dT) cellulose chromatography of the ribosomes
To isolate poly(A) mRNA–mRNP complexes, the polysomes were
ﬁrst suspended in a solution containing 30 mM EDTA, 0.5% NP-40,
20 mM Tris-HCl, pH 7.5 (Pellet Buffer); kept on ice for 10 min; and
centrifuged at 100,000×g for 2 h. The mRNPs, free 40S, and 60S
ribosomal subunits and a small subfraction of monosomes were
pelleted. The pellet was then resuspended in the pellet buffer and
spun at 14,000×g for 2 min. The supernatant was saved and KCl
concentration was adjusted to 200 mM and then incubated with 40 μl
of pre-washed oligo(dT) cellulose (100 mg/ml) with constant
rotation overnight at 4 °C. Poly(A) mRNAs and associated proteins
were eluted using 10 mM Tris-HCL, pH 7.5, at 65 °C or using SDS
sample buffer. The sample buffer eluate was used for Western blot
analysis and the Tris buffer eluate was used for immunoprecipitation
with LRBP antibody followed by qPCR analysis using RNA isolated
from the immune complex. qPCR analysis was also done using RNA
isolated directly from Tris buffer eluate.
2.9. In vitro transcription
Rat LH receptor cDNA containing T7 promoter at the 5′ end and
FLAG tag at the 3′ end and β-actin cDNA with T7 RNA polymerase
promoter at the 5′ end and T3 RNA polymerase promoter at the 3′ end
were synthesized as previously described [10]. The full-length capped
Fig. 1. Downregulation of LH receptor mRNA in the post-mitochondrial supernatants
and ribosomes of pseudopregnant rats injected with hCG. Rats were injected with hCG
on the 5th day of pseudo-pregnancy; ovaries were collected 0, 2, 4, 6, and 12 h later;
and polysomes were isolated. Total RNA from the control (CTL) or hCG-treated post-
mitochondrial supernatant (S10) were reverse transcribed, and the resulting cDNAs
were subjected to real-time PCR using predesigned primers and probes for rat LH
receptor mRNA (A). Total RNA from the control (CTL) or hCG-treated polysomes were
reverse transcribed, and the resulting cDNAs were subjected to real-time PCR using
predesigned primers and probes for rat LH receptor mRNA (B), β-actin, GAPDH, and
RPS6 (C), as described in Materials and Methods. The graphs represent changes in
mRNA levels normalized to 18S rRNA and shown as fold change vs. control. Error bars
represent mean±SE. ⁎pb0.05, n=3.
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were synthesized using mMessage mMachine T7 Ultra kit. The cDNA
for generating the LRBP binding site (5′-GGCCUCGCCAGACUAUCU-
CUCACCUAUCUCCCUGUCAAAGU-3′; LBS) of LH receptor mRNA was
chemically synthesized with T7 RNA polymerase promoter at the 5′
end [2]. For gel shift analysis, [α-32P]-labeled RNA was in vitro
transcribed from this cDNA template using Ambion in vitro tran-
scription kit (Maxiscript T7).
2.10. In vitro translation
In vitro translation reactions (25-μl reaction volume) were
performed using a Flexi rabbit reticulocyte lysate system as per the
manufacturer's instructions (Promega). FLAG-tagged in vitro trans-
lated rat LH receptor was immunoprecipitated using anti-FLAG M2–
agarose afﬁnity gel according to the manufacturer's instructions
(Sigma) and subjected to SDS–PAGE and autoradiography.
2.11. RNA electrophoretic mobility shift analysis
RNA electrophoretic mobility shift analysis (REMSA) was per-
formed by incubating RSW from control and downregulated ovaries
with a ﬁxed concentration of [α-32P]UTP-labeled LBS, as described
previously [5]. The RNA–protein complexes were resolved by 5%
native polyacrylamide (70:1) gel electrophoresis and analyzed by
autoradiography.
2.12. Statistical analysis
Statistical analysis was carried out using one-way ANOVA followed
by the Tukey multiple comparison test. Values were considered
statistically signiﬁcant for pb0.05. Each experiment was repeated at
least three times with similar results. Blots and autoradiograms
shown are representative of a minimum of three experiments.
3. Results
3.1. Downregulation of LH receptor mRNA in the post-mitochondrial
supernatants and ribosomes of rat ovaries in response to hCG treatment
Experiments were conducted to examinewhether downregulation
of LH receptor mRNA in response to hCG treatment occurs in
polysome preparations. Pseudopregnant rats were injected with
hCG and ovaries were collected at 0, 2, 4, 6, and 12 h post-injection.
Post-mitochondrial supernatants and polysomes were isolated from
the ovaries. LH receptor mRNA expression was analyzed in the post-
mitochondrial supernatants (S10) and polysomes using real-time
PCR, as described in Materials and Methods. The results are shown in
Fig. 1. Consistent with our previous results [8], LH receptor mRNA
levels in the S10 fractions were found to progressively decrease after
hCG treatment, reaching a minimum level at 12 h (Fig. 1A). LH
receptor mRNA levels were signiﬁcantly lower at 4, 6, and 12 h
(pb0.05 vs. control). The polysome fractions showed a similar trend
(Fig. 1B). There was a 40% reduction in the mRNA levels as early as 2
h after hCG treatment. The levels continued to decline in a similar
manner as the S10 fractions and reached a maximum decline at 12 h.
There was no signiﬁcant difference in the levels of LH receptor mRNA
between different control samples at these time points (data not
shown). In addition, our earlier work has shown that no signiﬁcant
differences exist in the levels of LRBP between control ovaries
collected after 0, 2, 4, 6, or 12 h of saline treatment [13]. Therefore
only one control, isolated at 0 h, was used for all the experiments.
There was no signiﬁcant change in the levels of non-speciﬁc mRNAs
like β-actin, GAPDH, or ribosomal protein S6 in the polysome fractions
following hCG treatment when compared to control, thus providingfurther proof to the speciﬁcity of LH receptor downregulation
(Fig. 1C).
3.2. Mobilization of LRBP to the ribosomes in downregulated rat ovaries
To demonstrate that LRBP is mobilized to the ribosomes following
hCG treatment to downregulate the receptor, we examined the levels
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analysis with anti-LRBP antibody. As shown in Fig. 2, there was an
increase (2.62±0.6-fold vs. CTL) in the levels of LRBP in the
polysomes isolated from downregulated ovaries, observed after 2 h,
remaining high until 4 h (2.12±0.4-fold vs. CTL) and decreasing
slowly thereafter. To conﬁrm the purity of the isolated polysome
fractions, the blots were stripped and reprobed with antibody against
ribosomal protein S6, RPS6. The lanes containing the polysomes gave
intense signals for RPS6. A cytosolic fraction (S130) from down-
regulated rat ovary, which was used as a positive control for LRBP, did
not give any signal for RPS6, but cross-reacted with the antibody
against the cytosolic protein, heat shock protein 90β (HSP90β). The
isolated polysome fractions did not give any signal for HSP90β, which
is not known to associate with ribosomes [14].
To further conﬁrm the translocation of LRBP to the ribosomes, we
performed an FPLC-assisted gel ﬁltration analysis of the post-
mitochondrial supernatants from the control and 4-h downregulated
ovaries. In the absorbance proﬁles in Fig. 3A and B (top panels),
ribosomes formed the initial peak since the speciﬁc fractions from the
gel ﬁltration column corresponding to that peak (fractions 7–9)
showed the presence of 18S and 28S rRNA in agarose gel electropho-
resis (middle panels; Fig. 3A and B). Western blot analysis of the same
fractions (ribosomal fractions 7–9) showed intense bands for LRBP in
the downregulated samples (Fig. 3B; left lower panel) but not in
control samples (Fig. 3A; left lower panel), whereas in both conditions
the same fractions (fractions 7–9) showed the presence of RPS6 (data
not shown). It should be noted that the elution proﬁles of both
samples showed positive signals in Western blot analysis for LRBP
(Fig. 3A and B; right lower panels) in the fractions containing free
unbound cytosolic proteins (fractions 20–22).
3.3. Association of LRBP with LH receptor mRNA in the downregulated
rat ovaries
In order to demonstrate a physical connection between LRBP and
LH receptor mRNA during downregulation, we performed an
immunoprecipitation-coupled real-time PCR analysis. Brieﬂy, ribo-
somes from control and downregulated ovaries were solubilized inFig. 2.Mobilization of LRBP to the ribosomes in downregulated ovaries. Polysomes were
isolated from 0-h control (CTL) and 2-, 4-, 6-, and 12-h hCG-treated ovaries; solubilized
in SDS sample buffer; and subjected to Western blot analysis to detect LRBP using LRBP
antibody. The membranes were stripped and reprobed for RPS6 and then for HSP90β.
The blot shown is a representative of ﬁve independent experiments. The lower panel
shows the quantitative expression of LRBP normalized to RPS6. The graph represents
the mean of ﬁve experiments and error bars represent mean±SE. ⁎pb0.05, n=5.NET-2 buffer and immunoprecipitated using LRBP antibody. The RNA
isolated from this immune complex was then analyzed for the
presence of LH receptor mRNA by performing real-time RT-PCR using
LH receptor cDNA-speciﬁc primers for ampliﬁcation. As shown in Fig.
4, the levels of LH receptor mRNA bound to LRBP in the RNP complex
were signiﬁcantly higher in the downregulated ovaries when
compared to control ovaries. There was a steady increase in the
levels of LH receptor mRNA with downregulation, reaching a 2.5-fold
difference by 4 h and declining afterwards. A signiﬁcant (1.5-fold vs.
control) increase in the levels was observed even at 6 h, which,
however, declined to below control levels by 12 h. However,
ampliﬁcation of actin or GAPDH using speciﬁc primers showed
undetectable CT values in real-time PCR analysis (data not shown),
thus conﬁrming that there was no signiﬁcant association of non-
speciﬁc mRNAs with the immune complex isolated from the
ribosomes. This experiment provides proof for a direct and speciﬁc
association between LRBP and LH receptor mRNA in the ribosomes of
LH receptor downregulated ovaries.
This observationwas further conﬁrmed by a different approach, by
ﬁrst performing oligo(dT) cellulose chromatography to isolate mRNA
with associated proteins, followed by Western blot analysis to detect
LRBP. The mRNA–protein complex was then immunoprecipitated
with LRBP antibody followed by real-time PCR to identify LH receptor
mRNA in themRNP complex. To start, polysomeswere resuspended in
Tris–HCl buffer containing 30 mM EDTA to disrupt the polyribosomes
and to release poly(A) mRNA–mRNP complexes. The fractions
containing mRNPs, free 40S, and 60S subunits and a small subfraction
of monosomes were then subjected to oligo(dT) cellulose chroma-
tography, as described in Materials and Methods. Poly(A) mRNA-
binding proteins eluted with SDS sample buffer were subjected to
Western blot analysis using LRBP antibody. The results are presented
in Fig. 5A. LRBP was found to be associated with the mRNP complexes
at 2, 4, and 6 h after treatment with hCG to downregulate LH receptor
mRNA expression. Additionally, elution of poly(A) mRNA–mRNP
complexes using Tris–HCl buffer without KCl followed by immuno-
precipitation with LRBP antibody, RNA isolation, and real-time PCR
analysis was done to conﬁrm that LRBP is bound speciﬁcally to LH
receptor mRNA. Consistent with the earlier results, there was a
signiﬁcant increase in the levels of LH receptor mRNA associated with
LRBP in the ribosomes following 2, 4, and 6 h of hCG treatment,
approximately 1.6- to 2-fold increase when compared to control (Fig.
5B). Importantly, the association was found to decrease to below
control level at 12 h, in a similar manner as observed in the previous
experiment (Fig. 4). To conﬁrm that equal amounts of poly(A)mRNA–
mRNP complexes were eluted from the column, the eluates were
subjected to real-time PCR analysis using primers for non-speciﬁc
genes like β-actin, GAPDH, and RPS6. There was no change in the
levels of β-actin, GAPDH, or RPS6 mRNA between control or down-
regulated samples (Fig. 5C).
3.4. Evidence for the LH receptor mRNA-binding activity in the
polysomes
To examine the binding ability of ribosome-associated LRBP to
bind LH receptor mRNA, gel shift analysis was performed by
incubating RSW with a ﬁxed concentration of radiolabeled LRBP
binding site (LBS) of LH receptor mRNA [2]. Polysomes were isolated
from control and downregulated ovaries after 4 h of hCG injection and
used for ribosomal salt wash preparation. This time frame was chosen
based on our earlier experiments that showed maximum RNA-
binding activity occurring at the onset of accelerated receptor–mRNA
degradation [8] and the strong association of LRBP with ribosomes
observed at 4 h (Fig. 2). Samples were processed as described in
Materials and Methods and were resolved by 5% native–polyacryl-
amide gel electrophoresis. As shown in Fig. 6, an appreciable amount
of mRNA-binding activity was exhibited by LRBP present in the RSW.
Fig. 3. Gel ﬁltration chromatography of post-mitochondrial supernatants from control (CTL; A) and downregulated (hCG; B) ovaries. Rats were injected with hCG or saline on the 5th
day of pseudopregnancy, ovaries were collected after 4 h; and the S10 fractions were subjected to FPLC-assisted gel ﬁltration. The top panels in (A) and (B) show the absorbance
proﬁle at 280 and 260 nm. The middle panels show the agarose gel electrophoresis proﬁle of RNA extracted from fractions 7–24 from the gel ﬁltration column, placed under the
corresponding fractions in the absorbance proﬁle. The bottom panels show Western blot analysis to detect LRBP using LRBP antibody in fractions 7–24, with the LRBP lanes placed
directly under the corresponding fractions of the absorbance proﬁle.
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Fig. 4. LH receptor mRNA co-precipitates with LRBP in the ribosomes from down-
regulated ovaries. Polysomes prepared from 0-h control (CTL) and downregulated
(hCG) pseudopregnant rat ovaries collected at 2, 4, 6, and 12 h after hCG treatment
were subjected to immunoprecipitation using LRBP antibody. Total RNA extracted from
the immune complex was reverse transcribed and the cDNAs were used for real-time
PCR using predesigned primers and probes for rat LH receptor mRNA. The graph
represents changes in LH receptor mRNA levels normalized to 18S rRNA and shown as
fold change vs. control. Error bars represent mean±SE. ⁎pb0.05, n=3.
Fig. 5. Co-precipitation of LRBP and LH receptor mRNA in the oligo(dT) eluted mRNP
fraction. mRNA-binding proteins in the polysomes from 0-h control (CTL) and
downregulated (hCG) pseudopregnant rat ovaries collected at 2, 4, 6, and 12 h after
hCG treatment were separated using oligo(dT) cellulose chromatography as described
in detail in Materials and Methods. Proteins from the oligo(dT) cellulose bound mRNP
complexes were eluted using SDS sample buffer and subjected to Western blot analysis
using LRBP antibody (A). The blot shown is a representative of three independent
experiments. Oligo(dT) cellulose bound mRNPs were eluted using 10 mM Tris–HCl, pH
7.5, and subjected to immunoprecipitation using LRBP antibody. The immune complex
was reverse transcribed and the cDNAs were used for real-time PCR using predesigned
primers and probes for rat LH receptor mRNA (B). Total RNA was also extracted from
the mRNP eluate directly and was reverse transcribed and subjected to real-time PCR
analysis using predesigned primers and probes for rat β-actin, GAPDH, and RPS6 (C).
The graphs represents changes in mRNA levels normalized to 18S rRNA, and are shown
as fold changes vs. control. Error bars represent mean±SE. ⁎pb0.05, n=3.
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observed in the samples containing RSWs but not in the negative
control containing only labeled LBS. Samples containing RSW
prepared from downregulated polysomes showed increased mRNA-
binding activity when compared to the control. This experiment
clearly shows that LRBP present in the polysomes retains its ability to
bind to LH receptor mRNA and further supports the notion that
mobilization of LRBP to the ribosomes occurs following ligand-
induced downregulation.
3.5. Inhibition of translation of LH receptor mRNA by polysomes from
downregulated ovaries
To demonstrate the role of ribosome-associated LRBP in the
inhibition of translation, in vitro translation of FLAG-tagged LH
receptor mRNA was performed in the presence of polysomes from
control and 4-h downregulated ovaries, and the resulting translated
proteins were subjected to immunoprecipitation with anti-FLAG M2
followed by SDS–PAGE and autoradiography. The results (Fig. 7A)
show that there is a decrease (0.5±0.03-fold vs. CTL, pb0.05) in the
amount of translated protein in the sample containing polysomes
from downregulated ovaries when compared to the control. This
supports our hypothesis that interaction of ribosome-associated LRBP
with LH receptor mRNA results in the inhibition of LH receptor mRNA
translation. This is not due to general impairment of the translation
machinery since there is no change in the translation of the pool of
mRNAs generally present in the ribosomes or that of a housekeeping
gene like β-actin (Fig. 7B). In the absence of any exogenously added
mRNA, the translation rate was unaffected by the addition of
polysomes from control or downregulated ovaries (lanes 1 and 2).
Similarly, when β-actin mRNA was in vitro translated in the presence
of control and downregulated polysomes (lanes 3 and 4), there was
no change in the protein synthesis, thus indicating that the inhibitory
effect on LH receptor mRNA translation by polysomes from down-
regulated ovaries was speciﬁc to LH receptor mRNA.
4. Discussion
The results presented in this study show that LRBPmobilizes to the
polysomes and associates with LH receptor mRNA during hCG-
induced downregulation, providing strong evidence for the notion
that LRBP interacts with the translational apparatus via its association
with LH receptor mRNA. The data from Western blot analysis of the
polysomes and FPLC-assisted gel ﬁltration of the post-mitochondrialsupernatant from the ovarian homogenates substantiate the associ-
ation of LRBP with the polysomes during ligand-induced down-
regulation. The association of speciﬁc mRNA-binding proteins with
ribosomes appears to be a general mechanism of post-transcriptional
regulation. Other examples are ribosomal association of Fragile X
Mental Retardation Protein, more commonly referred to as FMRP
[15,16], association of the RNA-binding protein ELAV/HuR with
HSP70 mRNA in the ribosomes following H2O2-mediated oxidative
stress [17], and the ribosomal association of polysome-associated
mRNA endonuclease, PMR1, that initiates the destabilization of
albumin mRNA causing the endonuclease-mediated mRNA decay
[18]. However, there are other examples where proteins directly bind
to the ribosomal subunits. For example, Rbm3, a glycine-rich RNA-
Fig. 6. RNA mobility shift analysis. Gel mobility shift analysis was performed with 32P-
labeled rat LBS (1.5×105 cpm) using no protein (LBS only) or equal amounts of protein
from the RSW extracted from control (CTL) and 4-h hCG-treated ovaries (hCG), as
described in Materials and Methods. The autoradiogram shown is representative of
three independent experiments.
Fig. 7. In vitro translation of LH receptor mRNA; effect of polysome-associated LRBP.
FLAG-tagged rat LH receptor mRNA (200 ng; A) was in vitro translated using 15 μCi of
[35S]methionine in the presence of ribosomes from control (CTL) and 4-h hCG-injected
(hCG) ovaries. The translated LH receptor protein was immunoprecipitated and
subjected to SDS–PAGE. The gel was dried and exposed to X-ray ﬁlm for
autoradiography. The experiment was repeated four times with the same results. The
lower panel shows the quantitative expression of LHR. The graph represents the mean
of four experiments and error bars represent mean±SE. ⁎pb0.05, n=4. (B) In vitro
translation was conducted in the presence of ribosomes from control (CTL) and 4-h
hCG-treated (hCG) ovaries in the absence of any exogenously addedmRNA (lanes 1 and
2) or by using human β-actin mRNA (100 ng; lanes 3 and 4). Lane 5 was β-actin mRNA
(200 ng) without polysomes. Translated proteins were directly subjected to SDS–PAGE
and autoradiography.
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mia, has been demonstrated to bind directly to the 60S ribosomal
subunit and regulate global levels of protein synthesis under normal
and cold-stress conditions [19]. Our present results demonstrate that
the association of LRBP with polyribosomes occurs through its
interaction with LH receptor mRNA.
The association of LH receptor mRNA with LRBP in the ribosomes
was seen as early as 2 h of downregulation and remains high even
after 6 h (Fig. 4). Therewas no observable association after 12 h of hCG
treatment; in fact it was even below the control levels. This is not
surprising, considering the fact that there is hardly any mRNA left in
the ribosomes at this time period (Fig. 1B). This supports the notion
that during downregulation, LRBP mobilizes to the ribosomes and
associates with LH receptor mRNA and then the LH receptor mRNA–
LRBP complex is subsequently routed for degradation. Control of
mRNA stability by translational regulation has been well documented
[20]. Examples include c-fos and granulocyte–macrophage colony-
stimulating factor ARE subsets that mediate selective mRNA degra-
dation through polysome-associated mechanisms coupled with
ongoing translation [21]. Another example is SgrS, a bacterial small
RNA that has been shown to form a speciﬁc ribonucleoprotein
complex with RNase E through RNA chaperone Hfq and inhibits the
translation and RNase E-dependent degradation of ptsG mRNA [22].
The loss of cell surface receptors can be due to several mechanisms
including the sequestration of the receptor to the intracellular
compartments, the loss of ligand binding activity, or decreased
receptor expression. Our previous studies have shown that LH
receptor levels closely correlate with the LH receptor mRNA levels
and the transcription rate is unaffected during downregulation [4].
These observations suggest that the loss of LH receptor seen during
hCG-induced downregulation is attributed mainly due to the loss of
mRNA. The demonstration of LH receptor mRNA-binding activity and
inhibition of translation by LRBP-rich polysomes from downregulated
ovaries in vitro supports the notion that LRBP associates with mRNA
leading to mRNA decay in vivo. Several mechanisms have been
proposed for the degradation of mRNAs involving interaction with
trans-acting factors, including, but not limited to, stress granules and
p bodies [20,23–26]. Stress granules are transient structures,
assembled as a consequence of interrupted RNA translation, and
contain mRNA still associated with some of the translational
machinery [23]. P bodies contain 5′→3′ exonucleolytic activity as
well as some of the RNA silencingmachinery [27] and hence can serve
both as sites of mRNA silencing and decay [28,29]. Since LH receptor
mRNA is almost totally depleted in the ovary by treatment with hCG
[30,31], it will be interesting to see if LH receptor mRNAs are
compartmentalized into P bodies or stress granules.
The present study providesmechanistic insights into the inhibition
of translation of LH receptor mRNA by LRBP. Here we show that LRBPmobilizes to the ribosomes during ligand-induced downregulation
prior to the observed decrease in the levels of LH receptor mRNA.
Using different biochemical approaches, we also show that the
mobilized LRBP binds directly to the LH receptor mRNA associated
with the ribosomes and inhibits its translation. The ability to regulate
the LH receptor expression at the post-transcriptional level could be a
rapid and efﬁcient way to control the receptor expression, especially
in response to the constantly changing hormonal milieu during the
ovarian cycle. The present study reveals a novel mechanism for the
1794 B. Menon et al. / Biochimica et Biophysica Acta 1793 (2009) 1787–1794regulation of expression of LH receptor, a crucial molecule required
for mammalian reproduction.
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